Applications
Clinical trial patient stratification
Stratify trial cohorts by proteomic phenotype.
Patients who share a diagnosis rarely share the same biology — and a trial that can't tell them apart risks diluting a real effect into a null result. Proteomic phenotyping reveals functional subgroups and response-associated signatures beneath a single label. We profile trial samples at scale with standardized, QC-controlled workflows that keep multi-site, longitudinal cohorts comparable, so stratification decisions hold up.
Example projects
Typical study designs
- Baseline stratification cohorts
- Responder vs. non-responder signatures
- Longitudinal on-treatment monitoring
- Molecular subtyping within a diagnosis
- Enrichment-marker discovery for trial design
Let's plan your study
Every study that is executed incorrectly consumes valuable sample material, and, more importantly, wastes time and manpower. In our fast-paced scientific environment, these resources cannot be recovered.